4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 985.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,600.00
  • 52 Week Low: 960.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 1
  • Market Cap: £152.64m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £11,009,227
Amy Walker 44,016 £433,558
Maria Del Pilar de la Huerta 6,667 £65,670
Hansjörg Plaggemars 6,667 £65,670
Timothy Paul McCarthy 2,388 £23,522

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,115,852 £50,391,142
DELPHI Unternehmensberatung AG 5,115,852 £50,391,142
M&G Plc 4,627,741 £45,583,249
Elevage Medical Technologies Holdings 4,627,741 £45,583,249
Deutsche Balaton AG 4,432,637 £43,661,474
4bb AG 3,665,242 £36,102,634
2invest AG 2,229,083 £21,956,468
Sparta AG 1,351,718 £13,314,422
Latonba AG 778,891 £7,672,076
Franciscus De Busschere 537,255 £5,291,962

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 985.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,600.00
52 Week Low 960.00
Volume 1
Shares Issued 15.50m
Market Cap £152.64m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.48% below the market average64.48% below the market average64.48% below the market average64.48% below the market average64.48% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
26.49% below the market average26.49% below the market average26.49% below the market average26.49% below the market average26.49% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Income Not Available
Growth
57.92% above the market average57.92% above the market average57.92% above the market average57.92% above the market average57.92% above the market average
74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average

4basebio Dividends

No dividends found

Trades for 20-Jun-2025

Time Volume / Share Price
08:10 0 @ 1,010.00p
08:10 1 @ 960.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page